Collection of cervical cells at colposcopy using a novel technique for analysis of high-risk vs low-risk lesions

Not Applicable

Completed

• Conditions: Cervical cancer; Cancer; Malignant neoplasm of cervix uteri

• Registration Number: ISRCTN13994246
• Lead Sponsor: Cambridge University Hospitals NHS Foundation Trust

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-09-14
• Study Completion: 2023-04-30
• Last Update Posted: 24 June 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 14

Inclusion Criteria

1. Participant is willing and able to give informed consent for participation in the study
2, Female, aged 25 years or above
3. Diagnosed with abnormal cervical cytology by routine screening

Exclusion Criteria

1. Participant is unable to give consent
2. Pregnant
3. HIV/systemic Immunosuppression

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Correlation between high-risk and low-risk cervical disease identified using the filter disc and by the standard method

Secondary Outcome Measures

Name	Time	Method
There are no secondary outcome measures